Advertisement
Advertisement
U.S. Markets open in 5 hrs 37 mins
Advertisement
Advertisement
Advertisement
Advertisement

Bavarian Nordic A/S (BVNRY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
9.47-0.40 (-4.05%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9.87
Open9.57
Bid0.00 x 0
Ask0.00 x 0
Day's Range9.43 - 9.66
52 Week Range5.85 - 19.31
Volume122,579
Avg. Volume256,011
Market Cap1.999B
Beta (5Y Monthly)1.22
PE Ratio (TTM)34.39
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMar 27, 2020
1y Target EstN/A
  • GlobeNewswire

    Luc Debruyne Appointed as Observer to the Board of Directors of Bavarian Nordic

    COPENHAGEN, Denmark, September 20, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the board of directors has appointed Luc Debruyne as an observer to the board with the intent to nominate him for election to the board at the ordinary general meeting in March 2023, where he following the board’s constitution is expected to assume the chairmanship after Gerard van Odijk, who will step down after having served for 15 years on the board. Luc Debruyne is former President Global Vaccines

  • GlobeNewswire

    Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for the Supply of Smallpox and Monkeypox Vaccine to Canada

    New contract amendment with Public Health Agency of Canada for the supply of IMVAMUNE valued at USD 234 million, with additional options spanning 10 years valued at USD 180 millionUnder the new contract amendment, the majority of the confirmed order will be delivered in 2023Furthermore, a multi-year contract valued at up to USD 20 million has been signed with the Canadian Department of National Defence, until 2031 COPENHAGEN, Denmark, September 20, 2022 – Bavarian Nordic A/S (OMX: BAVA) announce

  • GlobeNewswire

    Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

    COPENHAGEN, Denmark, September 7, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 2,150,430 as a consequence of employees’ exercise of warrants. The capital increase was effected without any pre-emption rights for the existing shareholders of the Company or others. The shares were subscribed for in cash at the following prices per share of nominally DKK 10: 214,983 shares at DKK 142.00 and 60 shares at DKK 239.60. The to

Advertisement
Advertisement